# The Role of Advanced Magnetic Resonance Imaging Sequences in Multiple Sclerosis

## TL;DR

This study shows that advanced MRI techniques provide more detailed insights into multiple sclerosis, improving diagnosis and treatment.

## Contribution

The study evaluates the clinical relevance of advanced MRI sequences in MS using a large, diverse patient cohort.

## Key findings

- Advanced MRI sequences revealed distinct biomarkers like higher mean diffusivity in white matter lesions.
- Functional MRI showed differences in BOLD signals in cognitive regions compared to normal-appearing white matter.
- DTI and MTI identified reduced fractional anisotropy and magnetization transfer ratio in MS lesions.

## Abstract

Background

The neurological condition known as multiple sclerosis (MS) is crippling and has a complicated pathogenesis as well as a wide range of clinical symptoms, including fatigue, difficulty walking, numbness or tingling, muscle spasms and spasticity, weakness, vision problems, dizziness and vertigo, bladder and bowel dysfunction, cognitive impairment, and emotional changes. The complete scope of MS pathology cannot be fully captured by conventional magnetic resonance imaging (MRI) sequences, which has led to the investigation of sophisticated MRI methods for better diagnosis and treatment.

Objective

This study aims to evaluate the clinical relevance of advanced MRI sequences in multiple sclerosis.

Methodology

A retrospective cohort study was conducted across multiple specialized medical centers renowned for treating neurological disorders, particularly multiple sclerosis, and involved 310 patients with diverse geography seeking treatment throughout 2022. Records were searched to obtain patient information, demographics, and treatment history. Descriptive statistics and t-tests were among the statistical studies that investigated relationships between MRI biomarkers and clinical factors to help with the diagnosis and treatment of MS. A p-value of <0.05 was significant.

Results

The research group consisted of 310 MS patients, the majority of whom were female (67.42%) and had a mean age of 34.7 years. With hypertension (14.52%) and hyperlipidemia (19.35%) as prevalent comorbidities, the majority of patients (72.26%) were on disease-modifying treatments. The results of advanced MRI showed that lesions with white matter had higher mean diffusivity (1.25 ± 0.15 mm²/s) on DWI, lesions with reduced magnetization transfer ratio (MTR) (0.15 ± 0.03) on MTI, and lesions with reduced fractional anisotropy (FA) (0.40 ± 0.08) on diffusion tensor imaging (DTI). Additionally, the blood oxygen level-dependent (BOLD) signals in cognitive processing regions (0.75 ± 0.10) on functional MRI were different from those with normal-appearing white matter (0.40 ± 0.08).

Conclusion

Advanced MRI sequences are essential for bettering MS diagnosis, prognosis, and treatment because they link imaging biomarkers to important clinical parameters, which improves patient care and quality of life.